Director buying at NervGen Pharma (NGEN)
Brian Eric Bayley, a Director, acquired 250,000 Common Shares at a price of $2.100USD and 125,000 Warrants exercisable at $2.650 on a direct ownership basis through a private transaction on November 19th, 2025. This represents a $737,100 investment into the company's shares and an account share holdings change of 79.4%.
Let the insiders guide you to opportunity at Canadianinsider.com.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.